Bharat Parenterals Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 604 million compared to INR 595.7 million a year ago. Revenue was INR 629.2 million compared to INR 616.1 million a year ago. Net income was INR 79.5 million compared to INR 64.5 million a year ago. Basic earnings per share from continuing operations was INR 13.88 compared to INR 11.26 a year ago. Diluted earnings per share from continuing operations was INR 13.88 compared to INR 11.26 a year ago. For the six months, sales was INR 1,212.4 million compared to INR 1,144.8 million a year ago. Revenue was INR 1,255.2 million compared to INR 1,190.2 million a year ago. Net income was INR 156.8 million compared to INR 130.9 million a year ago. Basic earnings per share from continuing operations was INR 27.37 compared to INR 22.85 a year ago. Diluted earnings per share from continuing operations was INR 27.37 compared to INR 22.85 a year ago.